123 related articles for article (PubMed ID: 9178935)
1. Prolongation of antidiuretic response to desmopressin acetate by iontophoretic transdermal delivery in rats.
Nakakura M; Kato Y; Ito K
Biol Pharm Bull; 1997 May; 20(5):537-40. PubMed ID: 9178935
[TBL] [Abstract][Full Text] [Related]
2. Safe and efficient transdermal delivery of desmopressin acetate by iontophoresis in rats.
Nakakura M; Kato Y; Ito K
Biol Pharm Bull; 1998 Mar; 21(3):268-71. PubMed ID: 9556158
[TBL] [Abstract][Full Text] [Related]
3. Effect of iontophoretic patterns on in vivo antidiuretic response to desmopressin acetate administered transdermally.
Nakakura M; Terajima M; Kato Y; Hayakawa E; Ito K; Kuroda T
J Drug Target; 1995; 2(6):487-92. PubMed ID: 7773610
[TBL] [Abstract][Full Text] [Related]
4. Effect of pulse on iontophoretic delivery of desmopressin acetate in rats.
Nakakura M; Kato Y; Hayakawa E; Ito K; Kuroda T
Biol Pharm Bull; 1996 May; 19(5):738-40. PubMed ID: 8741586
[TBL] [Abstract][Full Text] [Related]
5. The antidiuretic action of 1-deamino-8-D-arginine vasopressin (DDAVP) in man.
Radó JP; Marosi J; Szende L; Borbély L; Takó J; Fischer J
Int J Clin Pharmacol Biopharm; 1976 Apr; 13(3):199-209. PubMed ID: 950263
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of the antidiuretic response of kidneys to different modes of vasopressin administration].
Grigor'ev AI; Larina IM; Buravkova LB; Goncharova AG; Dobrokhotov IV; Natochin IuV
Fiziol Cheloveka; 2003; 29(3):89-97. PubMed ID: 12845788
[No Abstract] [Full Text] [Related]
7. [Antidiuretic reaction of the human and rat kidney to peroral administration of arginine-vasopressin and desmopressin].
Natochin IuV; Grigor'ev AI; Buravkova LB; Larina IM; Prutskova NP; Shakhmatova EI
Ross Fiziol Zh Im I M Sechenova; 2003 Feb; 89(2):184-92. PubMed ID: 12710188
[TBL] [Abstract][Full Text] [Related]
8. Antidiuretic responses to injected desmopressin, alone and with indomethacin.
Moses AM; Moses LK; Notman DD; Springer J
J Clin Endocrinol Metab; 1981 May; 52(5):910-3. PubMed ID: 7228994
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment of partial nephrogenic diabetes insipidus with thiazide and desmopressin.
Mizuno H; Fujimoto S; Sugiyama Y; Kobayashi M; Ohro Y; Uchida S; Sasaki S; Togari H
Horm Res; 2003; 59(6):297-300. PubMed ID: 12784095
[TBL] [Abstract][Full Text] [Related]
10. Relationship between the dose of 1-deamino-8-d-arginine vasopressin (ddavp) and the antidiuretic response in man.
Radó JP; Marosi J; Fischer J; Takó J; Kiss N
Endokrinologie; 1975 Nov; 66(2):184-95. PubMed ID: 1236681
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of central diabetes insipidus using oral DDAVP. Comparison with intranasal treatment].
Carraro A; Fano M; Porcella E; Bernareggi V; Giusti M
Minerva Endocrinol; 1991; 16(3):141-5. PubMed ID: 1806811
[TBL] [Abstract][Full Text] [Related]
12. Improved oral delivery of desmopressin via a novel vehicle: mucoadhesive submicron emulsion.
Ilan E; Amselem S; Weisspapir M; Schwarz J; Yogev A; Zawoznik E; Friedman D
Pharm Res; 1996 Jul; 13(7):1083-7. PubMed ID: 8842050
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics, pharmacodynamics, long-term efficacy and safety of oral 1-deamino-8-D-arginine vasopressin in adult patients with central diabetes insipidus.
Lam KS; Wat MS; Choi KL; Ip TP; Pang RW; Kumana CR
Br J Clin Pharmacol; 1996 Sep; 42(3):379-85. PubMed ID: 8877030
[TBL] [Abstract][Full Text] [Related]
14. Central diabetes insipidus in children. Antidiuretic effect and pharmacokinetics of intranasal and peroral 1-deamino-8-D-arginine vasopressin.
Fjellestad-Paulsen A; Tubiana-Rufi N; Harris A; Czernichow P
Acta Endocrinol (Copenh); 1987 Jul; 115(3):307-12. PubMed ID: 3618082
[TBL] [Abstract][Full Text] [Related]
15. Antidiuretic action of oxytocin is associated with increased urinary excretion of aquaporin-2.
Joo KW; Jeon US; Kim GH; Park J; Oh YK; Kim YS; Ahn C; Kim S; Kim SY; Lee JS; Han JS
Nephrol Dial Transplant; 2004 Oct; 19(10):2480-6. PubMed ID: 15280526
[TBL] [Abstract][Full Text] [Related]
16. [Effectiveness of and tolerability to oral desmopressin in the treatment of central diabetes insipidus].
Merola B; Caruso E; De Chiara G; Rossi E; Longobardi S; Colao A; Brusco G; Lombardi G; Biraghi M
Minerva Med; 1992 Dec; 83(12):805-13. PubMed ID: 1491760
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of diabetes insipidus with Minirin. Switch from nasal to oral administration].
Czernichow P
Ann Endocrinol (Paris); 1998 Dec; 59(5):407-9. PubMed ID: 9949892
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a new antidiuretic agent, desmopressin acetate (DDAVP).
Kosman ME
JAMA; 1978 Oct; 240(17):1896-7. PubMed ID: 691204
[TBL] [Abstract][Full Text] [Related]
19. Antidiuretic effect and pharmacokinetics of oral 1-desamino-8-D-arginine vasopressin. 1. Studies in adults and children.
Williams TD; Dunger DB; Lyon CC; Lewis RJ; Taylor F; Lightman SL
J Clin Endocrinol Metab; 1986 Jul; 63(1):129-32. PubMed ID: 3711257
[TBL] [Abstract][Full Text] [Related]
20. Oral DDAVP is a good alternative therapy for patients with central diabetes insipidus: experience of five-year treatment.
Fukuda I; Hizuka N; Takano K
Endocr J; 2003 Aug; 50(4):437-43. PubMed ID: 14599118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
